Manifesto to Improve Lives of COPD Patients
By HospiMedica staff writers Posted on 09 Dec 2002 |
In Europe, 19 patient associations have formed the European Network of Chronic Obstructive Pulmonary Disease (COPD) Patients' Association (ENCPA) to launch the first patient manifesto outlining the rights of COPD patients and challenging healthcare professionals to improve their lives. The manifesto was announced on November 20, 2002, to coincide with World COPD Day.
COPD is Europe's fifth largest killer, says ENCPA, and its prevalence is projected to rise. Despite this, recognition and diagnosis of the disease are low. An estimated 75% of people in Europe with COPD are unaware they have the disease.
A key point of the manifesto is the need to improve prevention strategies that outline the key risk factors for COPD: tobacco smoke and occupational exposure to dusts and air pollution. Early diagnosis is also seen as a critical factor, to ensure that effective treatment strategies can be started at the early stages of the disease and help slow the decline in quality of life.
"Our manifesto clearly sets out our demands to European policy makers and healthcare professionals to make a change. COPD is reaching epidemic proportions, so we must work together to ensure that predicted increases in the personal and economic burden never become reality,” said Erkka Valovirta, president of the European Federation of Allergy and Airways Diseases Patients' Associations (EFA), which includes ENCPA and represents more than 100 million allergy, asthma, and COPD patients in Europe.
Related Links:
EFA
COPD is Europe's fifth largest killer, says ENCPA, and its prevalence is projected to rise. Despite this, recognition and diagnosis of the disease are low. An estimated 75% of people in Europe with COPD are unaware they have the disease.
A key point of the manifesto is the need to improve prevention strategies that outline the key risk factors for COPD: tobacco smoke and occupational exposure to dusts and air pollution. Early diagnosis is also seen as a critical factor, to ensure that effective treatment strategies can be started at the early stages of the disease and help slow the decline in quality of life.
"Our manifesto clearly sets out our demands to European policy makers and healthcare professionals to make a change. COPD is reaching epidemic proportions, so we must work together to ensure that predicted increases in the personal and economic burden never become reality,” said Erkka Valovirta, president of the European Federation of Allergy and Airways Diseases Patients' Associations (EFA), which includes ENCPA and represents more than 100 million allergy, asthma, and COPD patients in Europe.
Related Links:
EFA
Latest Critical Care News
- Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
- Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
- Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
- Generative AI Technology Detects Heart Disease Earlier Than Conventional Methods
- Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery
- Wearable Health Monitoring Device Measures Gases Emitted from and Absorbed by Skin
- Groundbreaking Technology Rapidly Detects Airborne Influenza Viruses
- Handheld Device Could Transform Heart Disease Screening
- Flexible Semi-Autonomous Robot Could Deliver Medicine Inside Body
- Neurorestorative Treatment Strategies Hold Promise for Most Severe Forms of Epilepsy
- Gene Discovery Could Help Grow New Heart Arteries
- Study Discovers Invisible Transmission of Common Hospital-Associated Infection
- Non-Invasive Neuro-Ophthalmology Techniques Could Detect Brain Tumors Earlier
- Mass Manufactured Nanoparticles to Deliver Cancer Drugs Directly to Tumors
- World’s Smallest Pacemaker Fits Inside Syringe Tip
- AI-Powered, Internet-Connected Medical Devices to Revolutionize Healthcare, Finds Study
Channels
Surgical Techniques
view channel
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more